Tag Archives: More

More Data on the Neuroactive Steroid Zuranolone for Postpartum Depression

While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been finishing up its Phase 3 trials. Like brexanolone, SAGE-217 is a neuroactive steroid, an analogue of allopregnanolone which is a… Read More »

Perimenopausal Depression in Women with More Variable Levels of Estradiol and Lower Progesterone Levels

Women are at increased risk for depressive symptoms during the menopause transition.  It has long been suspected that falling estrogen levels play a role in triggering the onset of depression; however, if all women experience declining levels of estrogen and progesterone during this transition, why is it that only some women suffer from depression in… Read More »

Study: Black patients more likely than white patients to use telehealth because of pandemic

A new study published this week in the Journal of the American Medical Informatics Association showed that in mid-March, Black people were more likely to self-report telehealth use in response to the novel coronavirus pandemic – particularly when perceiving COVID-19 as a minor threat to their own health. The Pew Research Center conducted the survey… Read More »

How Glennon Doyle’s ‘Untamed’ captured Adele’s heart — and millions more

Adele’s outer transformation has shocked fans worldwide. But it’s her mind makeover that’s really making waves. “This book will shake your brain and make your soul scream,” Adele, 32, gushed of “Untamed,” a new memoir by Glennon Doyle, in a lengthy Instagram post published Saturday. “I am so ready for myself after reading this book!… Read More »